Starter Pack Focus

Improve your focus with nootropic supplements. One starter pack contains the following nootropics:

• Ginkgo Biloba: 7 capsules (120mg per capsule)
• Alpha-GPC: 7 capsules (200mg per capsule)
• Rhodiola Rosea: 7 capsules (200mg per capsule)
• 5-HTP: 7 capsules (100mg per capsule)

Each of these Focus supplements can have a beneficial effect to improve your focus and to boost your productivity. Some of the known effects are:

• Ginkgo Biloba has shown to have many benefits such as cognitive improvement (1)
• Alpha-GPC has shown a possible association with improved cognition and higher learning capacity (2)
• Rhodiola Rosea has shown to help for scattered, unfocused thinking (3)
• 5-HTP has shown to increase your body’s production of serotonin and optimizes cognitive functions (4, 5, 6)

References

1. Cieza A, Maier P, Pöppel E. Effects of Ginkgo biloba on mental functioning in healthy volunteers. Arch Med Res. 2003;34(5):373-381. doi:10.1016/j.arcmed.2003.05.001
2. Schettini G, Ventra C, Florio T, et al. Molecular mechanisms mediating the effects of L-alpha-glycerylphosphorylcholine, a new cognition-enhancing drug, on behavioral and biochemical parameters in young and aged rats. Pharmacol Biochem Behav. 1992;43(1):139-151. doi:10.1016/0091-3057(92)90650-5.
3. Brondino N., Silvestri, De A., Re S., Lanati N. A Systematic Review and Meta-Analysis of Ginkgo biloba in Neuropsychiatric Disorders: From Ancient Tradition to Modern-Day Medicine. Published online 2013 May 28. doi: 10.1155/2013/915691
4. Praag, van H.M., Korf J., Dols L.C., Schut T. A pilot study of the predictive value of the probenecid test in application of 5-hydroxytryptophan as antidepressant. PMID: 4556909 DOI: 10.1007/BF00422612
5. Kious B.M., Sabic H. , Sung Y.H. , Kondo D.G., Renshaw P. An Open-Label Pilot Study of Combined Augmentation With Creatine Monohydrate and 5-Hydroxytryptophan for Selective Serotonin Reuptake Inhibitor- or Serotonin-Norepinephrine Reuptake Inhibitor-Resistant Depression in Adult Women. PMID: 28787372 PMCID: PMC5578880 DOI: 10.1097/JCP.0000000000000754